Acrivon Therapeutics, Inc. (ACRV)
1.76
+0.04
(+2.33%)
USD |
NASDAQ |
Oct 15, 13:58
Acrivon Therapeutics Price to Book Value : 0.8702 for Oct. 15, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 14, 2026 | 0.8504 |
| October 13, 2026 | 0.8652 |
| October 12, 2026 | 0.9394 |
| October 09, 2026 | 0.9443 |
| October 08, 2026 | 0.9245 |
| October 07, 2026 | 0.9295 |
| October 06, 2026 | 0.9196 |
| October 05, 2026 | 0.9789 |
| October 02, 2026 | 0.9839 |
| October 01, 2026 | 0.9937 |
| September 30, 2026 | 1.014 |
| September 29, 2026 | 1.028 |
| September 28, 2026 | 1.018 |
| September 25, 2026 | 1.038 |
| September 24, 2026 | 1.048 |
| September 23, 2026 | 1.018 |
| September 22, 2026 | 1.063 |
| September 21, 2026 | 0.9937 |
| September 18, 2026 | 0.9146 |
| September 17, 2026 | 0.8405 |
| September 16, 2026 | 0.8405 |
| September 15, 2026 | 0.9048 |
| September 14, 2026 | 0.969 |
| September 11, 2026 | 0.9888 |
| September 10, 2026 | 1.009 |
| Date | Value |
|---|---|
| September 09, 2026 | 0.9839 |
| September 08, 2026 | 1.038 |
| September 04, 2026 | 1.053 |
| September 03, 2026 | 1.018 |
| September 02, 2026 | 1.063 |
| September 01, 2026 | 1.023 |
| August 31, 2026 | 1.033 |
| August 28, 2026 | 1.018 |
| August 27, 2026 | 1.063 |
| August 26, 2026 | 1.028 |
| August 25, 2026 | 1.078 |
| August 24, 2026 | 1.088 |
| August 21, 2026 | 1.093 |
| August 20, 2026 | 1.088 |
| August 19, 2026 | 1.182 |
| August 18, 2026 | 1.014 |
| August 17, 2026 | 1.014 |
| August 14, 2026 | 0.9641 |
| August 13, 2026 | 0.9146 |
| August 12, 2026 | 0.8504 |
| August 11, 2026 | 0.8553 |
| August 10, 2026 | 0.8603 |
| August 07, 2026 | 0.8553 |
| August 06, 2026 | 0.8355 |
| August 05, 2026 | 0.8108 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.591 |
| Alnylam Pharmaceuticals, Inc. | 22.96 |
| Anika Therapeutics, Inc. | 2.028 |
| Savara, Inc. | 6.820 |
| Vericel Corp. | 5.717 |
Price to Book Value Related Metrics
| Price | 1.76 |
| Earnings Yield | -107.1% |
| Market Cap | 75.41M |